Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 177

Similar articles for PubMed (Select 16609061)

1.

Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma.

Panka DJ, Atkins MB, Mier JW.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2371s-2375s. Review.

2.
4.
5.

Is B-Raf a good therapeutic target for melanoma and other malignancies?

Madhunapantula SV, Robertson GP.

Cancer Res. 2008 Jan 1;68(1):5-8. doi: 10.1158/0008-5472.CAN-07-2038. Review.

6.

Detection of mutations in the mitogen-activated protein kinase pathway in human melanoma.

Alsina J, Gorsk DH, Germino FJ, Shih W, Lu SE, Zhang ZG, Yang JM, Hait WN, Goydos JS.

Clin Cancer Res. 2003 Dec 15;9(17):6419-25.

7.

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.

Roberts PJ, Der CJ.

Oncogene. 2007 May 14;26(22):3291-310. Review.

PMID:
17496923
8.

Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.

Ou YC, Yang CR, Cheng CL, Raung SL, Hung YY, Chen CJ.

Eur J Pharmacol. 2007 Jun 1;563(1-3):49-60. Epub 2007 Feb 8.

PMID:
17341418
9.

Absence of mutations of the BRAF gene and constitutive activation of extracellular-regulated kinase in malignant melanomas of the uvea.

Weber A, Hengge UR, Urbanik D, Markwart A, Mirmohammadsaegh A, Reichel MB, Wittekind C, Wiedemann P, Tannapfel A.

Lab Invest. 2003 Dec;83(12):1771-6.

PMID:
14691295
10.

Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis.

Chetoui N, Sylla K, Gagnon-Houde JV, Alcaide-Loridan C, Charron D, Al-Daccak R, Aoudjit F.

Mol Cancer Res. 2008 Jan;6(1):42-52. doi: 10.1158/1541-7786.MCR-07-0080.

11.

Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.

Gollob JA, Wilhelm S, Carter C, Kelley SL.

Semin Oncol. 2006 Aug;33(4):392-406. Review.

PMID:
16890795
12.

Ras-associated protein-1 regulates extracellular signal-regulated kinase activation and migration in melanoma cells: two processes important to melanoma tumorigenesis and metastasis.

Gao L, Feng Y, Bowers R, Becker-Hapak M, Gardner J, Council L, Linette G, Zhao H, Cornelius LA.

Cancer Res. 2006 Aug 15;66(16):7880-8.

13.

Targeting the Raf/MEK/ERK pathway with small-molecule inhibitors.

McCubrey JA, Milella M, Tafuri A, Martelli AM, Lunghi P, Bonati A, Cervello M, Lee JT, Steelman LS.

Curr Opin Investig Drugs. 2008 Jun;9(6):614-30.

PMID:
18516761
14.

Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.

Yip-Schneider MT, Klein PJ, Wentz SC, Zeni A, Menze A, Schmidt CM.

J Pharmacol Exp Ther. 2009 Jun;329(3):1063-70. doi: 10.1124/jpet.108.147306. Epub 2009 Mar 3.

15.

ERK1/2 is highly phosphorylated in melanoma metastases and protects melanoma cells from cisplatin-mediated apoptosis.

Mirmohammadsadegh A, Mota R, Gustrau A, Hassan M, Nambiar S, Marini A, Bojar H, Tannapfel A, Hengge UR.

J Invest Dermatol. 2007 Sep;127(9):2207-15. Epub 2007 May 17.

16.

Mitogen-actived protein kinase activation is an early event in melanoma progression.

Cohen C, Zavala-Pompa A, Sequeira JH, Shoji M, Sexton DG, Cotsonis G, Cerimele F, Govindarajan B, Macaron N, Arbiser JL.

Clin Cancer Res. 2002 Dec;8(12):3728-33.

17.

Ras-mediated intestinal epithelial cell transformation requires cyclooxygenase-2-induced prostaglandin E2 signaling.

Repasky GA, Zhou Y, Morita S, Der CJ.

Mol Carcinog. 2007 Dec;46(12):958-70.

PMID:
17477350
18.
19.
20.

A novel BH3 mimetic reveals a mitogen-activated protein kinase-dependent mechanism of melanoma cell death controlled by p53 and reactive oxygen species.

Verhaegen M, Bauer JA, Martín de la Vega C, Wang G, Wolter KG, Brenner JC, Nikolovska-Coleska Z, Bengtson A, Nair R, Elder JT, Van Brocklin M, Carey TE, Bradford CR, Wang S, Soengas MS.

Cancer Res. 2006 Dec 1;66(23):11348-59.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk